Drug Shortage Report for ALDACTAZIDE 50
Report ID | 27679 |
Drug Identification Number | 00594377 |
Brand name | ALDACTAZIDE 50 |
Common or Proper name | ALDACTAZIDE |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE SPIRONOLACTONE |
Strength(s) | 50MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 TAB/BTL |
ATC code | C03EA |
ATC description | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-11-08 |
Estimated end date | |
Actual end date | 2018-03-21 |
Shortage status | Resolved |
Updated date | 2018-03-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2018-03-23 | French | Compare |
v11 | 2018-03-23 | English | Compare |
v10 | 2018-01-22 | French | Compare |
v9 | 2018-01-22 | English | Compare |
v8 | 2017-12-14 | French | Compare |
v7 | 2017-12-14 | English | Compare |
v6 | 2017-12-07 | English | Compare |
v5 | 2017-11-15 | French | Compare |
v4 | 2017-11-15 | English | Compare |
v3 | 2017-11-01 | French | Compare |
v2 | 2017-11-01 | English | Compare |
v1 | 2017-11-01 | English | Compare |
Showing 1 to 12 of 12